Ekso Bionics appoints CEO Scott G. Davis to its Board of Directors

EKSO BIONICS HOLDINGS, INC.

Appointment effective Dec 8, 2022; term expires at 2023 Annual Meeting.
Davis previously served as President and COO before becoming CEO.
No arrangements or understandings with any person for his board election.
No family relationships or material interest in reportable transactions.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Scott G. Davis

Director

CHRN · EKSO BIONICS HOLDINGS, INC.

Effective: 2022-12-08
Filed: December 9, 2022, 6:59 PM ET

On December 8, 2022, effective immediately, the Board of Directors (the “Board”) of Ekso Bionics Holdings, Inc. (the “Company”) appointed Scott G. Davis to serve as a director of the Company

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Scott G. Davis was appointed as Director at EKSO BIONICS HOLDINGS, INC..

Action: appointed
Role: Director

Exact text from the filing

On December 8, 2022, effective immediately, the Board of Directors (the “Board”) of Ekso Bionics Holdings, Inc. (the “Company”) appointed Scott G. Davis to serve as a director of the Company

View on SEC.gov

EKSO BIONICS HOLDINGS, INC. filing history →

Source: SEC EDGAR

accession 0001549084-22-000080

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.